Thermo Fisher Science公司估计收入, 提出2025年的指导, 并宣布股票回购。 Thermo Fisher Scientific beat earnings estimates, raised 2025 guidance, and announced a share buyback.

Themore Fisher Science报告Q3收入丰厚,为5.79 EPS和11.12亿美元收入,超过估计值,比年增长4.9%。 Thermo Fisher Scientific reported strong Q3 earnings, with $5.79 EPS and $11.12 billion in revenue, surpassing estimates and marking a 4.9% year-over-year growth. 该公司将2025年财政收入指导提高到每股22.60至22.86美元,并宣布了一项股票回购方案。 The company raised its fiscal 2025 earnings guidance to $22.60–$22.86 per share and announced a share repurchase program. 机构投资者增加了他们的股权,股票交易额为585.19美元,具有协商一致的“收购”评级,价格目标为601.65美元。 Institutional investors increased their stakes, and the stock, trading at $585.19, has a consensus "Moderate Buy" rating and a price target of $601.65.